Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C10H12FNO3 |
| Molecular Weight | 212.2081 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 1 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
N[C@H](CC1=CC=C(OC[18F])C=C1)C(O)=O
InChI
InChIKey=GEBHVOHKNWLITQ-DEVVULMSSA-N
InChI=1S/C10H12FNO3/c11-6-15-8-3-1-7(2-4-8)5-9(12)10(13)14/h1-4,9H,5-6,12H2,(H,13,14)/t9-/m1/s1/i11-1
BAY-86-9596 (D-18F-FMT, or O-18F-fluoromethyl-D-tyrosine) was developed as an agent not only for tumor detection but also for monitoring early-phase response to radiation therapy by positron emission tomography (PET). This drug participated in clinical trials for patients with inflammation and solid tumors, but further information about trials is not available.
Approval Year
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
DB15296
Created by
admin on Sat Dec 16 10:14:07 GMT 2023 , Edited by admin on Sat Dec 16 10:14:07 GMT 2023
|
PRIMARY | |||
|
870452-26-9
Created by
admin on Sat Dec 16 10:14:07 GMT 2023 , Edited by admin on Sat Dec 16 10:14:07 GMT 2023
|
PRIMARY | |||
|
11579379
Created by
admin on Sat Dec 16 10:14:07 GMT 2023 , Edited by admin on Sat Dec 16 10:14:07 GMT 2023
|
PRIMARY | |||
|
300000041416
Created by
admin on Sat Dec 16 10:14:07 GMT 2023 , Edited by admin on Sat Dec 16 10:14:07 GMT 2023
|
PRIMARY | |||
|
58HVN5SR99
Created by
admin on Sat Dec 16 10:14:07 GMT 2023 , Edited by admin on Sat Dec 16 10:14:07 GMT 2023
|
PRIMARY |
ACTIVE MOIETY
